Commercial launch planning should begin early in Phase II, says the company
QPharma (Morristown, NJ), which offers a variety of consulting services, mostly in the commercial operations realm, is expanding its reach with an advisory service for clinical products. Peter Shaw, chief medical officer, says that the service is especially attuned to small- to medium-sized biopharma companies that are trying to reach the commercialization phase in drug development.
Services include recruiting, training, and managing sales teams; engaging clinical key opinion leaders; ensuring compliance with federal and state regulations; establishing programs for the management and distribution of samples; and designing and launching appropriate marketing campaigns. Shaw adds that Qpharma has relationships with a number of specialized consulting organizations that can be brought into the process; among these is Qforma (Morris Plains, NJ; which, despite its name, is separate from QPharma). Qforma has a software package called Ilaunch that is essentially a project-management tool for drug commercialization.
Boosting Patient Adherence: The Power of Clinical Support Programs
October 3rd 2024In this podcast, we speak with Amanda Scholz, UBC Senior Clinical Program Manager, MHA, BSN, RN as we discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.